Non-melanocytic lesions mimicking melanocytic lesions

Pathology
E Calonje

Abstract

Distinction between benign and malignant melanocytic lesions commonly represents a big challenge for the pathologist. Equally difficult is separating tumours with melanocytic lineage from those displaying other lines of differentiation. This is because benign and malignant melanocytic lesions are able to display a wide range of histological appearances that frequently closely mimic reactive and neoplastic lesions (benign and malignant). This applies to processes with almost any line of differentiation. Difficulties in differential diagnosis are mainly found in melanocytic lesions restricted to the dermis or those in which the junctional component is minimal. Although purely junctional melanocytic lesions less commonly pose a problem in differential diagnosis, they may be very problematic, especially in small biopsies. Immunohistochemistry is usually a very important aid in the differential diagnosis of mimics of melanocytic lesions but pitfalls often occur. This is particularly true when small samples are analysed and when close clinicopathological correlation is lacking. This review discusses the histological differential diagnosis of mimics of melanocytic lesions. These mimics are separated into those primarily presenting in ...Continue Reading

References

Apr 1, 1978·The British Journal of Dermatology·M P JamesI W Whimster
Nov 1, 1992·The American Journal of Surgical Pathology·S C Rayne, D J Santa Cruz
Feb 1, 1990·The American Journal of Surgical Pathology·R L Barnhill, M C Mihm
Aug 1, 1990·The American Journal of Dermatopathology·A J MarrogiD J Cruz
Apr 1, 1986·Southern Medical Journal·L RosenB Frank
Jul 1, 1986·The American Journal of Surgical Pathology·E F DiCarloR A Erlandson
Apr 1, 1987·American Journal of Clinical Pathology·M R WickJ C Manivel
May 1, 1988·Archives of Dermatology·S M Dinehart, R L Sanchez
May 1, 1989·The American Journal of Surgical Pathology·S Jain, P W Allen
Jan 1, 1985·The American Journal of Dermatopathology·B Peison, B Benisch
Jul 1, 1986·International Journal of Dermatology·S H BlobsteinP L Myskowski
Sep 1, 1985·Journal of the American Academy of Dermatology·N B EsterlyF Gonzalez-Crussi
Jun 1, 1983·Journal of the American Academy of Dermatology·R M Mandojana, E B Helwig
Mar 15, 1983·Cancer·B S Ducatman, B W Scheithauer
Jan 1, 1983·Journal of the American Academy of Dermatology·P SubrtE B Smith
May 1, 1983·Journal of the American Academy of Dermatology·C Camisa, W Roberts
Nov 1, 1980·Journal of the American Academy of Dermatology·P M OlmsteadD D Leonard
Jan 1, 1981·The American Journal of Dermatopathology·C Wood
Jan 1, 1980·The American Journal of Dermatopathology·C Wood, G L Severin
Jan 1, 1981·Cancer·J P Fields, E B Helwig
Aug 1, 1995·Journal of the American Academy of Dermatology·T T KuoM J Chen
Jan 1, 1994·Dermatology : International Journal for Clinical and Investigative Dermatology·A Bourlond
Nov 1, 1994·Histopathology·R J PrescottN Y Haboubi
Dec 1, 1993·The American Journal of Surgical Pathology·T A LongacreR V Rouse
Sep 23, 1997·The American Journal of Surgical Pathology·S KadduH P Soyer
Oct 23, 1997·The American Journal of Surgical Pathology·J R Goldblum, W R Hart
Apr 30, 1998·Hematology/oncology Clinics of North America·S Munn, A C Chu
May 15, 1998·The British Journal of Dermatology·P P PapageorgiouA C Chu
Jun 26, 1998·The British Journal of Dermatology·J Y Lee, S C Chao
Sep 16, 1998·The American Journal of Surgical Pathology·K J BusamC D Fletcher
Feb 23, 1999·The American Journal of Dermatopathology·E J Glusac, J M McNiff
Oct 27, 1999·The American Journal of Dermatopathology·I B Bayer-GarnerB Smoller
Nov 11, 1999·The American Journal of Surgical Pathology·A R WangG Scott

❮ Previous
Next ❯

Citations

Feb 28, 2014·Mediators of Inflammation·Thaís Regina ToledoAlexandra I Medeiros
Sep 22, 2010·Pathology·Mark J Wilsher
Apr 12, 2011·Histopathology·Jag Bhawan
Aug 14, 2012·Pathology, Research and Practice·Valeria BarresiGiovanni Tuccari
Oct 6, 2018·The American Journal of Dermatopathology·Cameron C Felty, Konstantinos Linos
May 29, 2018·Pathology Oncology Research : POR·Snježana KaštelanIvana Bakija

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.